- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02289287
Effects of a Self-Management Group-Intervention on Participation in Post-Stroke Patients.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Haifa,, Israel
- Clinical Research Unit, Clalit Health Services, Haifa and Western Galilee District,
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Cerebrovascular accident diagnosed 3-18 months before enrollment. Treated at th Neurologic Rehabilitation Center of Clalit Health Services in Kiryat Byalik, Israel.
Living in the community (in their homes). Are capable of basic communication in Hebrew.
Exclusion Criteria:
Moderate-severe stroke (National Institutes of Health Stroke Scale (NIHSS) score ≤ 16).
Moderate-Severe Cognitive impairment (Montreal Cognitive Assessment (MOCA) - total score ≤ 16). Inability to provide informed consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Self-Management group-intervention
Participants will receive Self-Management group-intervention + Standard Care
|
At enrollment eligible patients will be randomized to Intervention + Standard Care or Standard Care group.
Within 3 weeks after enrollment all participants will undergo baseline assessment using a predefined set of scales and questionnaires (intervention group will additionally undergo a semi-structured interview).
The group-intervention (SM program) will begin after enrollment of at least 4 participants to the intervention group, and within no longer than 5 weeks since enrollment.
The intervention will include 12 weekly sessions, each session 2.5 hour long, and will be based on well-known SM interventions that were found effective for stroke patients in the U.S. Follow-up assessments will be done at 12 and 36 week to examine long term effectiveness.
|
|
Active Comparator: Standard Care
Participants will receive Standard Care only
|
At enrollment eligible patients will be randomized to Intervention + Standard Care or Standard Care group.
Within 3 weeks after enrollment all participants will undergo baseline assessment using a predefined set of scales and questionnaires (intervention group will additionally undergo a semi-structured interview).
Standard care will include 'one-on-one' sessions in each paramedical discipline as given regularly in this setting (average of 15-20 sessions per patient).
Follow-up assessments will be done at 12 and 36 week to examine long term effectiveness.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Participation
Time Frame: 12 and 36 weeks
|
The primary outcome measure is the change in patient's participation, as defined by the International Classification of Function, Disability and Health (ICF), between the three assessment points - baseline, 12 and 36 weeks.
|
12 and 36 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-efficacy for self-management behaviors.
Time Frame: 12 and 36 weeks
|
Self-efficacy for self-management behaviors.
|
12 and 36 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Tamar Adar, MD, Clinical Research Unit, Clalit Health Services, Haifa District, HAIFA, ISRAEL
- Study Chair: Eli Carmeli, PhD, Department of Physical Therapy, Faculty of Social Well fare and Health Sciences, Haifa University, Haifa, Israel.
- Principal Investigator: Hagit Harel-Katz, MSc, Clinical Research Unit, Clalit Health Services, Haifa District, HAIFA, ISRAEL
- Study Director: Uzi Milman, MD, Clinical Research Unit, Clalit Health Services, Haifa District, HAIFA, ISRAEL
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- COM - 0018-14-CTIL
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
University Hospital HeidelbergCompletedAcute Ischemic Stroke | Acute Ischemic Stroke AIS | Acute Ischemic Stroke PatientsGermany
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
Clinical Trials on Self-Management group-intervention
-
University of Colorado, DenverUniversity Hospitals Cleveland Medical Center; U.S. Army Medical Research and... and other collaboratorsNot yet recruitingBrain CancerUnited States
-
Tel Aviv UniversityUnknownDevelopment and Evaluation of a Cognitive Rehabilitation Program for Persons With Multiple SclerosisMultiple Sclerosis | Cognitive ImpairmentIsrael
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedMultiple Sclerosis | Low Back Pain | Chronic Pain | Muscular Dystrophies | Spinal Cord Injury | Other and Unspecified Amputation Stump ComplicationsUnited States
-
Yale UniversityCompleted
-
Agency for Healthcare Research and Quality (AHRQ)The Commonwealth Fund; California HealthCare FoundationCompleted
-
Liberty Mutual Research Institute for SafetyCompletedChronic Physical Health ConditionsUnited States
-
Universidad de GranadaCompleted
-
University Health Network, TorontoCanadian Institutes of Health Research (CIHR)Completed
-
University of North Carolina, Chapel HillCompletedChronic Obstructive Pulmonary DiseaseUnited States